Victoza Cost Without Insurance: Assistance, Generics and Pharmacy Prices

Victoza now has an FDA-approved generic liraglutide alternative in the US, which makes generic availability an important part of any cost comparison. Patients should compare the prescribed liraglutide product and verify insurance coverage rather than relying only on the brand price.

Quick Answer

The FDA approved the first generic referencing Victoza in December 2024. For patients concerned about cost, ask the pharmacist whether FDA-approved generic liraglutide is available for the prescribed strength and use, and compare it with the current insured or cash cost of brand-name Victoza.

Last updated: Sep-26
•
Market: United States

1. Check the Manufacturer Program First

NovoCare continues to provide Victoza coverage resources, but the US market now also includes FDA-approved generic liraglutide referencing Victoza. The FDA approved the first generic liraglutide injection 18 mg/3 mL in December 2024. Approval does not guarantee that every pharmacy has stock, so availability and actual price should be checked directly.

Important

Manufacturer savings programs can have eligibility requirements and their terms can change. Check the current program directly before relying on a quoted saving or self-pay amount.

2. Compare the Same Prescription Across Pharmacies

For Victoza, compare the prescribed brand product with any FDA-approved generic liraglutide that the pharmacy can dispense for that prescription. Availability and formulary treatment can differ. MediSearcher does not currently have an active commercial relationship with a Victoza pricing provider on this page.

When comparing prices, make sure you are looking at the same medication, strength, quantity and supply period. Insurance copays, pharmacy cash prices, discount prices and manufacturer programs are different payment routes and may not be directly comparable.

3. Re-check Insurance and Formulary Rules

Check insurance coverage for the exact product being dispensed. Brand Victoza and generic liraglutide can have different formulary placement and out-of-pocket costs. NovoCare provides a coverage checker for Victoza, including an uninsured option that directs patients toward assistance resources.

4. Understand Online and Telehealth Access

Victoza and generic liraglutide require prescriptions. If purchasing through an online pharmacy or telehealth route, confirm the exact FDA-approved product, strength and dispensing pharmacy rather than assuming all liraglutide offers are equivalent.

Prescription required

Victoza is a prescription medication. A legitimate online or telehealth service should involve an appropriate evaluation by a licensed healthcare professional and should not guarantee a prescription before that evaluation.

5. If Victoza Is Still Unaffordable

If Victoza is unaffordable, ask the prescriber or pharmacist specifically about FDA-approved generic liraglutide and other covered diabetes treatments. Do not substitute Saxenda or another liraglutide product without clinical guidance because approved uses and dosing differ.

Frequently Asked Questions

Is there a generic for Victoza?

Yes. The FDA approved the first generic liraglutide injection referencing Victoza in December 2024. Pharmacy availability can vary.

Can generic liraglutide be cheaper than Victoza?

It may be, but the actual out-of-pocket cost depends on pharmacy pricing and insurance coverage. Compare the exact prescribed product at the time of purchase.

Does Victoza require a prescription?

Yes. Both brand-name Victoza and FDA-approved generic liraglutide are prescription medications.

Sources and Verification

Pricing programs, eligibility requirements and medication access can change. MediSearcher checked the sources below on 17/09/2026. Verify current terms with the provider, manufacturer, pharmacy or insurer before purchasing.

Editorial note: MediSearcher does not rank providers according to commission payments. Prices, savings programs and availability should be independently verified because they can change.

Medical disclaimer: This page is for general informational and price-comparison purposes. It does not provide medical advice or recommend a particular medication. Consult a licensed healthcare professional before starting, stopping or changing prescription treatment.

About the author

Mattias Hagman

Dr Mattias Hagman is the founder and editor of MediSearcher. He holds a PhD from the University of Sydney and has a background in academic research and scientific publishing. At MediSearcher, he researches online pharmacy services, medication access, consumer safety and the quality of health information available online.

View all articles by Mattias Hagman →